Options
Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention
Alzheimer's disease
Clinical trial and AD...
Disease-modifying dru...
Multitargeting compou...
Neurodegenerative dis...
Repositioning of old ...
ABC transporter subfa...
alicapistat
an 2
ban 2401
bca 909
bosutinib
brexanolone
df 302
donepezil
elenbecestat
gre 213
itanapraced
ladostigil
levetiracetam
ly 2599666
ly 3002813
microRNA
montelukast
neuroprotective agent...
nnz 2591
phenserine
pioglitazone
sar 228810
suvn 502
tak 71
tesamorelin
tropisetron
ue 2343
unclassified drug
unindexed drug
verubecestat
biological marker
Alzheimer disease
cerebrospinal fluid a...
cholinergic nerve cel...
disease course
drug effect
drug screening
human
metabolomics
mild cognitive impair...
nerve cell lesion
nerve degeneration
neuroimaging
nonhuman
priority journal
Review
risk factor
animal
cognitive defect
metabolism
Alzheimer Disease
Animals
Biomarkers
Cognitive Dysfunction...
Humans